SMTL ID : 9bsv.1

EBOV GP/Nanosota-EB2 complex

Coordinates
PDB Format
Method
ELECTRON MICROSCOPY
Oligo State
hetero-3-3-mer
Ligands
1 x NAG- NAG- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-4)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
1 x NAG- NAG- BMA- MAN- MAN- BMA- MAN: alpha-D-mannopyranose-(1-2)-[beta-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
1 x NAG- NAG- BMA- MAN- MAN- MAN: alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
1 x MAN: alpha-D-mannopyranose(Non-covalent)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Bu, F. et al., Discovery of Nanosota-EB1 and -EB2 as Novel Nanobody Inhibitors Against Ebola Virus Infection. Plos Pathog. (2024)
Release Date
2024-12-18
Peptides
Nanosota-EB2: AEF
Envelope glycoprotein: BCD
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
D
E
E
F
F
B
A
C
B
D
C

Nanosota-EB2

Toggle Identical (AEF)

Envelope glycoprotein

Toggle Identical (BCD)

Related Entries With Identical Sequence

9bsu.1